Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000812771 | SCV000953095 | benign | RASopathy | 2024-01-20 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002325588 | SCV002606475 | uncertain significance | Cardiovascular phenotype | 2019-09-06 | criteria provided, single submitter | clinical testing | The p.A1092T variant (also known as c.3274G>A), located in coding exon 20 of the SOS1 gene, results from a G to A substitution at nucleotide position 3274. The alanine at codon 1092 is replaced by threonine, an amino acid with similar properties. This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Genome- |
RCV002468065 | SCV002763233 | uncertain significance | Noonan syndrome 4 | criteria provided, single submitter | clinical testing | ||
Genome- |
RCV002468064 | SCV002763234 | uncertain significance | Fibromatosis, gingival, 1 | criteria provided, single submitter | clinical testing |